BIOMAT Database Logo BIOMAT Database Logo

ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. 1998

S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, California 94141, USA.

The synthesis of cholesterol esters by acyl-CoA:cholesterol acyltransferase (ACAT, EC 2.3.1.26) is an important component of cellular cholesterol homeostasis. Cholesterol ester formation also is hypothesized to be important in several physiologic processes, including intestinal cholesterol absorption, hepatic lipoprotein production, and macrophage foam cell formation in atherosclerotic lesions. Mouse tissue expression studies and the disruption of the mouse ACAT gene (Acact) have indicated that more than one ACAT exists in mammals and specifically that another enzyme is important in mouse liver and intestine. We now describe a second mammalian ACAT enzyme, designated ACAT-2, that is 44% identical to the first cloned mouse ACAT (henceforth designated ACAT-1). Infection of H5 insect cells with an ACAT-2 recombinant baculovirus resulted in expression of a approximately 46-kDa protein in cell membranes that was associated with high levels of cholesterol esterification activity. Both ACAT-1 and ACAT-2 also catalyzed the esterification of the 3beta-hydroxyl group of a variety of oxysterols. Cholesterol esterification activities for ACAT-1 and ACAT-2 exhibited different IC50 values when assayed in the presence of several ACAT-specific inhibitors, demonstrating that ACAT inhibitors can selectively target specific forms of ACAT. ACAT-2 was expressed primarily in mouse liver and small intestine, supporting the hypothesis that ACAT-2 contributes to cholesterol esterification in these tissues. The mouse ACAT-2 gene (Acact2) maps to chromosome 15 in a region containing a quantitative trait locus influencing plasma cholesterol levels. The identification and cloning of ACAT-2 will facilitate molecular approaches to understanding the role of ACAT enzymes in mammalian biology.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002785 Sterol O-Acyltransferase An enzyme that catalyzes the formation of cholesterol esters by the direct transfer of the fatty acid group from a fatty acyl CoA derivative. This enzyme has been found in the adrenal gland, gonads, liver, intestinal mucosa, and aorta of many mammalian species. EC 2.3.1.26. Acyl-CoA-Cholesterol Acyltransferase,Cholesterol Acyltransferase,Cholesterol Esterifying Enzyme,Acyl CoA Cholesterol Acyltransferase,Acyltransferase, Acyl-CoA-Cholesterol,Acyltransferase, Cholesterol,Enzyme, Cholesterol Esterifying,Esterifying Enzyme, Cholesterol,O-Acyltransferase, Sterol,Sterol O Acyltransferase
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Structure of the human acyl-CoA:cholesterol acyltransferase-2 (ACAT-2) gene and its relation to dyslipidemia.
April 2001, Biochimica et biophysica acta,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Effects of ethanol on the assay of acyl-CoA:cholesterol acyltransferase (ACAT)
June 1993, Clinica chimica acta; international journal of clinical chemistry,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Human acyl-CoA:cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis.
March 2006, Acta biochimica et biophysica Sinica,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes.
June 1997, Biochimica et biophysica acta,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
March 1996, Journal of medicinal chemistry,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
First identification of xanthone sulfonamides as potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
May 2010, Bioorganic & medicinal chemistry letters,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bond.
May 1993, Journal of medicinal chemistry,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.
December 2022, Journal of medicinal chemistry,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
Reversible translocation of acyl-CoA:cholesterol acyltransferase (ACAT) between the endoplasmic reticulum and vesicular structures.
January 2023, Frontiers in molecular biosciences,
S Cases, and S Novak, and Y W Zheng, and H M Myers, and S R Lear, and E Sande, and C B Welch, and A J Lusis, and T A Spencer, and B R Krause, and S K Erickson, and R V Farese
[Acyl-coenzyme A: cholesterol acyltransferase (ACAT)].
December 2004, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!